• FDA grants breakthrough designation for device to treat PTSD

    8 days ago - By Healio

    The FDA has granted breakthrough device designation to electroCore Inc. for its gammaCore device to be used in the treatment of PTSD in military personnel, according to a company release.
    “We appreciate the thorough and timely review by the FDA of our Breakthrough Device Request for gammaCore for the treatment of PTSD,” said Eric Liebler, senior vice president of neurology at electroCore. “The ability of (non-invasive vagus nerve stimulation ) to target several of the underlying causes of PTSD such as autonomic dysfunction, stress and inflammation, safely and
    Read more ...